DC-CIK cell therapy combined with transcatheter arterial chemoembolization and radiofrequency ablation for treatment of small hepatocellular carcinoma

World Chinese Journal of Digestology

Volumn 22, Issue 16, 2014, Pages 2237-2242

  Zhang, Quan Cheng ^a   Pan, Guo Zheng ^b   Li, Guo Qiang ^b   Yuan, Qing Zhong ^b   Xu, Jiao Bang ^b   Kong, Yang ^c   Wang, Li Ming ^c  

^a Shengli Petroleum Administration Bureau   (China)

^b China dmskzs238 163com   (China)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

DC CIK therapy; Radiofrequency ablation; Small hepatic carcinoma; Transcatheter arterial chemoembolization

Indexed keywords

ARTICLE; CD16+ T LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD56+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL THERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; RADIOFREQUENCY ABLATION; SURVIVAL TIME; T LYMPHOCYTE;

EID: 84901990084     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v22.i16.2237     Document Type: Article

References (21)

1. Wu FS, Zhao WH, Liang TB, Ma ZM, Teng LS, Wang M, Zheng SS. Survival factors after resection of small hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005; 4: 379-384 [PMID: 16109520]
2. Shen A, Zhang H, Tang C, Chen Y, Wang Y, Zhang C, Wu Z. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. J Gastroenterol Hepatol 2013; 28: 793-800 [PMID: 23432154 DOI: 10.1111/jgh.12162]
3. Min JH, Lee MW, Cha DI, Jeon YH, Shin SW, Cho SK, Rhim H, Lim HK. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography. Korean J Radiol 2013; 14: 248-258 [PMID: 23483753 DOI: 10.3348/kjr.2013.14.2.248]
4. Li H, Wang C, Yu J, Cao S, Wei F, Zhang W, Han Y, Ren XB. Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy 2009; 11: 1076-1083 [PMID: 19929470 DOI: 10.3109/14653240903121252]
5. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch DW, Burroughs AK. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30: 6-25 [PMID: 17103105 DOI: 10.1007/s00270-006-0062-3]
6. Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Nakashima Y, Ikeno H, Orito N, Matsui O. The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization. Cardiovasc Intervent Radiol 2010; 33: 513-522 [PMID: 19756862 DOI: 10.1007/s00270-009-9697-1]
7. Xiao EH, Guo D, Bian DJ. Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells. World J Gastroenterol 2009; 15: 4582-4586 [PMID: 19777619 DOI: 10.3748/wjg.15.4582]
8. Abitabile P, Maurer CA. Radiofrequency ablation of liver tumors: a novel needle perfusion technique enhances efficiency. J Surg Res 2010; 159: 532-537 [PMID: 19394647 DOI: 10.1016/j.jss.2008.08.037]
9. Lin SM. Local ablation for hepatocellular carcinoma in Taiwan: different points between Japan, Asia and West. Oncology 2010; 78 Suppl 1: 102-106 [PMID: 20616591 DOI: 10.1159/000315237]
10. Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol 2012; 81: e189-e193 [PMID: 21353417 DOI: 10.1016/j.ejrad.2011.01.122]
11. Chan WS, Poon WL, Cho DH, Chiu SS, Luk SH. Transcatheter embolisation of intrahepatic arteriovenous shunts in patients with hepatocellular carcinoma. Hong Kong Med J 2010; 16: 48-55 [PMID: 20124574]
12. Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol 2013; 31: 426-432 [PMID: 23269991 DOI: 10.1200/JCO.2012.42.9936]
13. Hou YB, Chen MH, Yan K, Wu JY, Yang W. Adjuvant percutaneous radiofrequency ablation of feeding artery of hepatocellular carcinoma before treatment. World J Gastroenterol 2009; 15: 2638-2643 [PMID: 19496195 DOI: 10.3748/wjg.15.2638]
14. Mizukoshi E, Yamashita T, Arai K, Sunagozaka H, Ueda T, Arihara F, Kagaya T, Yamashita T, Fushimi K, Kaneko S. Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma. Hepatology 2013; 57: 1448-1457 [PMID: 23174905 DOI: 10.1002/ hep.26153]
15. Hui D, Qiang L, Jian W, Ti Z, Da-Lu K. A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma. Dig Liver Dis 2009; 41: 36-41 [PMID: 18818130 DOI: 10.1016/j.dld.2008.04.007]
16. Chen J, Huang X, Huang G, Chen Y, Chen L, Song H. Preconditioning chemotherapy with cisplatin enhances the antitumor activity of cytokineinduced killer cells in a murine melanoma model. Cancer Biother Radiopharm 2012; 27: 210-220 [PMID: 22440093 DOI: 10.1089/cbr.2011.1116]
17. Sangiolo D, Mesiano G, Carnevale-Schianca F, Piacibello W, Aglietta M, Cignetti A. Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation. Expert Opin Biol Ther 2009; 9: 831-840 [PMID: 19463075 DOI: 10.1517/1471259090 3005552]
18. Huang B, Sikorski R, Sampath P, Thorne SH. Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancer. J Immunother 2011; 34: 289-296 [PMID: 21389869 DOI: 10.1097/ CJI.0b013e31820e1b0d]
19. Su X, Zhang L, Jin L, Ye J, Guan Z, Chen R, Guo T. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma. Cancer Biother Radiopharm 2010; 25: 465-470 [PMID: 20701541 DOI: 10.1089/cbr.2010.0762]
20. Lin G, Wang J, Lao X, Wang J, Li L, Li S, Zhang J, Dong Y, Chang AE, Li Q, Li S. Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells. J Immunother 2012; 35: 337-343 [PMID: 22495391]
21. Shi SB, Ma TH, Li CH, Tang XY. Effect of maintenance therapy with dendritic cells: cytokineinduced killer cells in patients with advanced nonsmall cell lung cancer. Tumori 2012; 98: 314-319 [PMID: 22825506]